The FDA has granted approval to Teal Health’s at-home vaginal sample self-collection device, Teal Wand, for cervical cancer ...

Two rival medical device companies specialising in scalp cooling technologies for cancer patients are merging to form a ...

The IRB has granted approval for FastWave to initiate a coronary feasibility study leveraging its Sola L-IVL system.

The National Institutes of Health (NIH) and the Centers for Medicare & Medicaid Services (CMS) are partnering to develop a ...

HeartBeam has secured two new US patents, strengthening its intellectual property (IP) portfolio in cardiac monitoring ...

Eye health company Bausch + Lomb has received the CE Mark approval in Europe for its LuxLife full range of vision intraocular ...

Endogenex has shared results from its REGENT-1 clinical study during the Digestive Disease Week (DDW) 2025 event held in San ...

A new AI model will be trained on a large set of NHS data in hopes of identifying early interventions for patient care.

The US Food and Drug Administration (FDA) has set an "aggressive" timeline to implement genAI across the agency by 30 June ...

GeneDx has completed the acquisition of Fabric Genomics, a US-based company focused on AI-driven human genomic interpretation ...

Natera has announced findings from a study evaluating its Signatera in individuals with soft tissue and bone sarcomas.

Inquis Medical has reported that the trial of its Aventus thrombectomy system for pulmonary embolism (PE) met its primary ...